Darusentan

From Citizendium
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
This article is developing and not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Darusentan&printable=yes
This editable Main Article is under development and subject to a disclaimer.
Darusentan.png
darusentan
IUPAC name: (2S)-2-(4,6-dimethoxypyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic

acid

Synonyms:
Formula: C22H22N2O6
 Uses: hypertension
 Properties:
 Hazards: see side effects & drug interactions
Mass (g/mol): CAS #:
410.41988 171714-84-4


In medicine, darusentan is a medication for treating hypertension that is a selective endothelin type A antagonist. It is a vasodilator.[1]

Drug toxicity

Fluid retention is the most common drug toxicity.[1]

References

  1. ↑ 1.0 1.1 Weber MA et al. (2009) A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet DOI:10.1016/S0140-6736(09)61500-2
Retrieved from "https://citizendium.org/wiki/index.php?title=Darusentan&oldid=687732"